Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Rosuvastatin Versus Coenzyme Q10 on Nonalcoholic Steatohepatitis
Latest Information Update: 18 May 2023
At a glance
- Drugs Ubidecarenone (Primary) ; Rosuvastatin
 - Indications Non-alcoholic steatohepatitis
 - Focus Therapeutic Use
 
Most Recent Events
- 13 May 2023 Planned initiation date changed from 1 Feb 2023 to 1 Jun 2023.
 - 17 Feb 2023 New trial record